Spartalizumab
Spartalizumab (PDR001) is a humanized immunoglobulin G4 monoclonal antibody that selectively binds to PD-1 at low concentrations, exhibiting high activity. It blocks the interaction with PD-L1 and PD-L2, making it suitable for studying undifferentiated thyroid cancer (ATC) .
Product Specifications
CAS Number
1935694-88-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
PD-1/PD-L1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
20509121 3x 1.0µg DNA
FGF7P1 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details 
49055114 3x 1.0 µg
Ubtfl1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
Sign In for Pricing
View Details 
LH10229V 100 µg
AMPK gamma 3 (PRKAG3) (NM_017431) Human Over-expression Lysate
Sign In for Pricing
View Details